NASDAQ
Ayala Pharmaceuticals, Inc. (ADXS) has a revenue compound annual growth rate of -70.74% over 5 years and -30.69% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.